EviCore, an independent company, updated its clinical guidelines for Radiation Oncology Services as of November 5, 2026. The updates apply to all Independence Blue Cross (IBX) and Independence Administrators plans participating in the EviCore Enhanced Utilization Management Program for Radiation Oncology.
Review the updated guidelines on EviCore's website.
New guideline
Revised guidelines
- Adrenal
- Bladder
- Breast
- Cervical
- Endometrial
- Esophageal
- Gastric
- Hepatobiliary
- IGRT
- Kidney
- Myeloma
- Non-Hodgkin Lymphoma
- Non-Malignant Disorders
| - NSCLC
- Pancreatic
- Primary Craniospinal
- Rectal
- SIRT
- Skin - Melanoma
- Skin - Non-Melanoma
- Small Cell Lung Cancer
- Soft Tissue Sarcomas
- Thymoma
- Urethral
- Vulvar
|
Learn more
Review the applicable medical policy for additional information:
Access the most current policy through the Medical and Claim Payment Policy Portal or review the Commercial and Medicare Advantage policy bulletins.
26-0204